PT91438A - Processo para a preparacao de novas 2-amino 4-morfolino-6-profil-1,3,5- -triazinas e dos seus sais - Google Patents

Processo para a preparacao de novas 2-amino 4-morfolino-6-profil-1,3,5- -triazinas e dos seus sais

Info

Publication number
PT91438A
PT91438A PT91438A PT9143889A PT91438A PT 91438 A PT91438 A PT 91438A PT 91438 A PT91438 A PT 91438A PT 9143889 A PT9143889 A PT 9143889A PT 91438 A PT91438 A PT 91438A
Authority
PT
Portugal
Prior art keywords
alkyl
triazines
propyl
amino
preparation
Prior art date
Application number
PT91438A
Other languages
English (en)
Other versions
PT91438B (pt
Inventor
Eric Cossement
Jean Gobert
Roland Boydens
Jacques Mathieu
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of PT91438A publication Critical patent/PT91438A/pt
Publication of PT91438B publication Critical patent/PT91438B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/08—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Cosmetics (AREA)
PT91438A 1988-08-16 1989-08-11 Processo para a preparacao de novas 2-amino 4-morfolino-6-profil-1,3,5- -triazinas e dos seus sais PT91438B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888819493A GB8819493D0 (en) 1988-08-16 1988-08-16 2-amino-4-morpholino-6-propyl-1 3 5-triazines

Publications (2)

Publication Number Publication Date
PT91438A true PT91438A (pt) 1990-03-08
PT91438B PT91438B (pt) 1995-05-04

Family

ID=10642235

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91438A PT91438B (pt) 1988-08-16 1989-08-11 Processo para a preparacao de novas 2-amino 4-morfolino-6-profil-1,3,5- -triazinas e dos seus sais

Country Status (28)

Country Link
US (1) US4956367A (pt)
EP (1) EP0356413B1 (pt)
JP (1) JPH02108675A (pt)
KR (1) KR0136108B1 (pt)
AT (1) ATE72241T1 (pt)
AU (1) AU614247B2 (pt)
CA (1) CA1317944C (pt)
CY (1) CY1709A (pt)
DE (1) DE68900794D1 (pt)
DK (1) DK171698B1 (pt)
ES (1) ES2038849T3 (pt)
FI (1) FI102065B1 (pt)
GB (1) GB8819493D0 (pt)
GR (1) GR3004267T3 (pt)
HK (1) HK95693A (pt)
HU (1) HUT58087A (pt)
IE (1) IE61205B1 (pt)
IL (1) IL91243A (pt)
LT (1) LT3601B (pt)
MY (1) MY105008A (pt)
NO (1) NO179206C (pt)
NZ (1) NZ230290A (pt)
PL (2) PL161161B1 (pt)
PT (1) PT91438B (pt)
RU (3) RU1806142C (pt)
SG (1) SG27893G (pt)
UA (1) UA11064A (pt)
ZA (1) ZA896222B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024617D0 (en) * 1989-12-05 1991-01-02 Ici Plc Heterocyclic compounds
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
IT1240690B (it) * 1990-04-30 1993-12-17 Ciba Geigy Ag Composti piperdin-triazinici atti all'impiego come stabilizzanti per materiali organici
GB9116039D0 (en) * 1991-07-25 1991-09-11 Ucb Sa Substituted cyclopropylamino-1,3,5-triazines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549757A (en) * 1968-03-27 1970-12-22 Shell Oil Co Use of 2-morpholino - 4 - amino-6-substituted-s-triazines for inducing depressant effects in animals
JPS4969688A (pt) * 1972-11-02 1974-07-05
FR2262512A1 (en) * 1974-03-01 1975-09-26 Synthelabo 2,4,6-Tri-substd. -1,3,5-triazines - with analgesic and psychotropic activity

Also Published As

Publication number Publication date
DK398189D0 (da) 1989-08-14
KR0136108B1 (ko) 1998-04-25
EP0356413A1 (fr) 1990-02-28
AU3991789A (en) 1990-04-05
HK95693A (en) 1993-09-24
ZA896222B (en) 1990-05-30
RU1822403C (ru) 1993-06-15
ES2038849T3 (es) 1993-08-01
FI102065B (fi) 1998-10-15
LTIP829A (en) 1995-02-27
KR900003165A (ko) 1990-03-23
US4956367A (en) 1990-09-11
DE68900794D1 (en) 1992-03-12
DK398189A (da) 1990-02-17
NZ230290A (en) 1991-10-25
DK171698B1 (da) 1997-03-24
FI102065B1 (fi) 1998-10-15
PL161161B1 (pl) 1993-05-31
NO179206C (no) 1996-08-28
HUT58087A (en) 1992-01-28
CY1709A (en) 1994-01-14
IL91243A0 (en) 1990-03-19
GR3004267T3 (pt) 1993-03-31
NO893279L (no) 1990-02-19
UA11064A (uk) 1996-12-25
ATE72241T1 (de) 1992-02-15
IE892619L (en) 1990-02-16
FI893714A (fi) 1990-02-17
PL161591B1 (pl) 1993-07-30
IL91243A (en) 1995-05-26
NO179206B (no) 1996-05-20
RU1806142C (ru) 1993-03-30
NO893279D0 (no) 1989-08-15
LT3601B (en) 1995-12-27
MY105008A (en) 1994-07-30
RU1838312C (ru) 1993-08-30
CA1317944C (en) 1993-05-18
SG27893G (en) 1993-06-25
JPH02108675A (ja) 1990-04-20
IE61205B1 (en) 1994-10-19
PT91438B (pt) 1995-05-04
FI893714A0 (fi) 1989-08-07
GB8819493D0 (en) 1988-09-21
EP0356413B1 (fr) 1992-01-29
AU614247B2 (en) 1991-08-22

Similar Documents

Publication Publication Date Title
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
BR9606755A (pt) Novos compostos de aminopiridina policíclica os quais são inibidores da aceticolinesterase processo para a sua preparação e seu uso
ATE75942T1 (de) Verwendung von 2-amino-4-morpholino-6-propyl1,3,5-triazin zur herstellung eines medikaments zur behandlung kognitiver und mentaler erkrankungen.
DE68923151D1 (de) Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen.
DK26289A (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
PT91438A (pt) Processo para a preparacao de novas 2-amino 4-morfolino-6-profil-1,3,5- -triazinas e dos seus sais
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
NO924098D0 (no) Tiadiazinonderivater, fremgangsmaate for fremstilling derav, samt farmasoeytiske preparater som inneholder minst ett av derivatene
ATE70827T1 (de) Benzhydryloxyaethyl-piperidine-derivate, verfahren zur herstellung und pharmazeutische zusammenstellungen, die diese enthalten.
PT90307A (pt) Processo para a preparacao de sulfonanilidas anti-hipertensivas
ATE4313T1 (de) Tyrosin-derivate, verfahren zu deren herstellung und eine sie enthaltende pharmazeutische zusammensetzung zur behandlung von hypertonie.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19941004

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000430